Barclays Downgrades Adient to Equal-Weight, Lowers Price Target to $43

Barclays analyst Brian Johnson downgrades Adient (NYSE:ADNT) from Overweight to Equal-Weight and lowers the price target from $50 to $43.

Barclays analyst Brian Johnson downgrades Adient (NYSE:ADNT) from Overweight to Equal-Weight and lowers the price target from $50 to $43.

Total
0
Shares
Related Posts